Efficacy of using angiotensin-converting enzyme inhibitors versus angiotensin II receptor antagonists as antiproteinuric treatment in children and teenagers with diabetes

被引：0
|
作者：
Jimenez Moreno, Marta [1 ]
Aguilar Rodriguez, Ana Cristina [1 ]
Calzada Banos, Yolanda [1 ]
Arango Sancho, Pedro [1 ]
Lopez Espinoza, Jarima [1 ]
Lopez-Baez, Victor [1 ]
Madrid Aris, Alvaro [1 ]
机构：
[1] St Joan de Deu Hosp, Pediat Nephrol, Barcelona, Spain
来源：
PEDIATRIC NEPHROLOGY | 2024年 / 39卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
1034
引用
收藏
页码：S92 / S93
页数：2
相关论文
共 50 条
  • [41] Effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on peritoneal transport
    Coronel, Francisco
    KIDNEY INTERNATIONAL, 2011, 79 (01) : 136 - 137
  • [42] Fracture Risk and Use of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers
    Holloway-Kew, Kara L.
    Betson, Amelia G.
    Anderson, Kara B.
    Sepetavc, Filip
    Gaston, James
    Kotowicz, Mark A.
    Liao, Wan-Hui
    Henneberg, Maciej
    Pasco, Julie A.
    CALCIFIED TISSUE INTERNATIONAL, 2022, 111 (04) : 396 - 408
  • [43] Prevention of atrial fibrillation by angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers
    Boos, CJ
    Lip, GYH
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 889 - 890
  • [44] Eczematous reactions due to angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers
    Vena, Gino A.
    Cassano, Nicoletta
    Coco, Valeria
    De Simone, Clara
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2013, 35 (03) : 447 - 450
  • [45] Fracture Risk and Use of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers
    Kara L. Holloway-Kew
    Amelia G. Betson
    Kara B. Anderson
    Filip Sepetavc
    James Gaston
    Mark A. Kotowicz
    Wan-Hui Liao
    Maciej Henneberg
    Julie A. Pasco
    Calcified Tissue International, 2022, 111 : 396 - 408
  • [46] Role of Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Aldosterone Antagonists in the Prevention of Atrial and Ventricular Arrhythmias
    Makkar, Kathy M.
    Sanoski, Cynthia A.
    Spinler, Sarah A.
    PHARMACOTHERAPY, 2009, 29 (01): : 31 - 48
  • [47] Protective effect of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor antagonists (ARBs) on microalbuminuria in diabetic patients
    Elsafa, Enas
    Ali, Pirzado Zahid
    CLINICAL DIABETOLOGY, 2020, 9 (03): : 193 - 200
  • [48] Angiotensin receptor blocker reduces proteinuria in children treated with angiotensin-converting enzyme inhibitors
    Seeman, T.
    Pohl, M.
    John, U.
    Misselwitz, J.
    PEDIATRIC NEPHROLOGY, 2009, 24 (04) : 918 - 918
  • [49] Receipt of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers among Medicare beneficiaries with diabetes and hypertension
    Wang, Junling
    Surbhi, Satya
    Kuhle, Julie W.
    JOURNAL OF PHARMACEUTICAL HEALTH SERVICES RESEARCH, 2014, 5 (01) : 67 - 74
  • [50] Progression of renal diseases - Angiotensin-converting enzyme inhibitors versus calcium antagonists
    不详
    SOUTH AFRICAN MEDICAL JOURNAL, 1996, 86 : C114 - C114
12345